Tazemetostat Hydrobromide

CHEMBL4594260 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
653.6 g/mol
LogP
Phase
4

Tazemetostat hydrobromide is the hydrobromide salt form of tazemetostat, an EZH2 histone methyltransferase inhibitor. See tazemetostat for complete pharmacological details. This salt formulation is used in certain clinical and investigational settings for lymphoma and melanoma.

Peso Molecular

653,6000 g/mol

TPSA

83,10 Ų

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Br.CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1

InChI

InChI=1S/C34H44N4O4.BrH/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40;/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H,35,39)(H,36,40);1H

Molecular Formula

C34H45BrN4O4

HBD / HBA

3 / 6

Ligações Rotacionáveis

9

Átomos Pesados

43

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Tazemetostat hydrobromide is the hydrobromide salt form of tazemetostat, an EZH2 histone methyltransferase inhibitor. See tazemetostat for complete pharmacological details. This salt formulation is used in certain clinical and investigational settings for lymphoma and melanoma.

Yes, Tazemetostat Hydrobromide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594260. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 71761627. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.